EastWest Bioscience Inc.

    EastWest Bioscience Inc.

    OOTC:HBOSF
    - -
    USD
    - -
    - -
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    0.02
    0.01
    0.01
    - -
    Basic EPS, GAAP
    -0.01
    -0.02
    -0.04
    -0.06
    -0.05
    -0.01
    -0.02
    - -
    Free Cash Flow per Basic Share
    -0.02
    -0.02
    -0.02
    -0.06
    -0.03
    - -
    -0.01
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.01
    -0.03
    -0.05
    0.05
    - -
    -0.01
    -0.01
    0.03
    Tangible Book Value per Share
    0.04
    0.02
    0.05
    0.05
    0.01
    - -
    - -
    0.03
    Basic Weighted Avg Shares
    2
    2
    6
    53
    79
    84
    95
    99
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    1
    1
    1
    - -
    Operating Margin (%)
    - -
    - -
    - -
    -2,237.17
    -208.8
    -151.49
    -205.59
    -674.22
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    -3
    -4
    -1
    -2
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    -2,538.98
    -262.49
    -122.68
    -256.23
    37.23
    Working Capital
    - -
    - -
    - -
    1
    -2
    -2
    -2
    -3
    LT Debt
    - -
    - -
    - -
    1
    - -
    - -
    - -
    - -
    Total Equity
    - -
    - -
    - -
    3
    1
    - -
    - -
    3
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    25.44
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    -282.62
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Oct'22
    Jan'22
    Apr'22
    ST Debt
    2
    2
    2
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    98
    101
    101
    Market Capitalization
    - -
    2
    - -

    Working Capital

    CAD

    •

    in mil. unless spec.
    Oct'22
    Jan'22
    Apr'22
    Total Current Assets
    1
    - -
    - -
    Cash, Cash Equivalents & STI
    1
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    4
    4
    4
    Payables & Accruals
    2
    1
    2
    ST Debt
    2
    2
    2
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    267.73%
    46.64%
    Free Cash Flow
    - -
    565.24%
    114.29%
    Net Income, GAAP
    - -
    383.79%
    41.8%
    Sales/Revenue/Turnover
    - -
    - -
    -32.1%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    - -
    - -
    - -
    - -
    1
    2021
    - -
    - -
    - -
    - -
    1
    2022
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    -0.01
    - -
    - -
    - -
    -0.01
    2021
    - -
    - -
    - -
    - -
    -0.02
    2022
    - -
    0.02
    -0.01
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    - -
    - -
    - -
    - -
    - -
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • accesswire.com

      EastWest Bioscience Announces Shares for Debt Settlement

    • accesswire.com

      EastWest Bioscience Announces Grant of Options and Debt Settlement

    • accesswire.com

      Eastwest Announces Resignation of CFO and Appointment of Interim CFO